When Paul O'Hara's health insurer denied him coverage for his life-saving cancer treatment, he wasn't willing to take no for an answer. The Bucks County, Pennsylvania, man credits his survival to the ...
Bristol Myers’ BMY legacy portfolio comprises Eliquis, Revlimid, Pomalyst, Sprycel and Abraxane. Revenues for the Legacy Portfolio plunged 20% in the first quarter to $5.64 billion due to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback